|
|
|
|
LEADER |
02521nam a22003015i 4500 |
001 |
000282235 |
005 |
20210723120029.0 |
007 |
cr nn 008mamaa |
008 |
161219s2016 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319460444
|
024 |
7 |
|
|a 10.1007/978-3-319-46044-4
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a GABAB Receptor /
|c edited by Giancarlo Colombo.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Humana,
|c 2016.
|
300 |
|
|
|a XX, 385 p. 64 illus., 19 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a The Receptors,
|v 29
|
505 |
0 |
|
|a 1. Historical Perspectives on the GABAB Receptor -- Section 1. Chemistry -- 2. Chemistry of GABAB Receptor Ligands: Focus on Agonists and Antagonists -- 3. Chemistry of GABAB Receptor Ligands: Focus on Positive Allosteric Modulators -- Section 2. Molecular Biology, Biochemistry, & Physiology -- 4. Molecular Structure and Trafficking of the GABAB Receptor -- 5. Distribution and Localization of the GABAB Receptor -- 6. Activation Mechanism and Allosteric Properties of the GABAB Receptor -- 7. Modulation of Neurotransmission by the GABAB Receptor -- 8. GABAB Receptor Functions In The Mesolimbic Dopamine System -- Section 3. Pharmacology -- 9. Drug Discrimination Studies for Investigations on the Mechanisms of Action of GABAB Receptor Ligands -- 10. Targeting the GABAB Receptor for the Treatment of Epilepsy -- 11. Targeting the GABAB Receptor for the Treatment of Pain -- 12. Targeting the GABAB Receptor for the Treatment of Psychiatric Disorders -- 13. Targeting the GABAB Receptor for the Treatment of Fragile X Syndrome and Autism Spectrum Disorders -- 14. Targeting the GABAB Receptor for the Treatment of Substance Use Disorder -- 15. Targeting the GABAB Receptor for the Treatment of Alcohol Use Disorder -- 16. Targeting GABAB Receptors for the Treatment of Gastroesophageal Reflux Disease and Chronic Cough -- 17. Baclofen: Therapeutic Use and Potential of the Prototypic GABAB Receptor Agonist -- 18. Allosteric Modulators: The New Generation of GABAB Receptor Ligands -- 19. GABAB Receptor Antagonists as Cognition Enhancers.
|
650 |
|
0 |
|a Neurosciences.
|
650 |
|
0 |
|a Neurology .
|
650 |
1 |
4 |
|a Neurosciences.
|
650 |
2 |
4 |
|a Neurology.
|
700 |
1 |
|
|a Colombo, Giancarlo.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|